Affera
Newton, US · 2 known investors
Affera develops a medical technology platform for treating cardiac arrhythmias, including atrial fibrillation, using innovative ablation solutions. The company serves cardiac electrophysiology specialists and healthcare systems treating arrhythmia patients.
Founders & leadership
DH
Doron HarlevinCEO, Founder
Investors · 2
In the news
An extra fiscal week benefited Medtronic's first-quarter underlying sales growth by about $570 million. Sales reached $9.8 billion, and the company raised its full-year outlook.stocktitan.net · Sep 2026
Medtronic reports first quarter fiscal 2027 results; delivers broad-based portfolio performance and raises fiscal 2027 guidanceprnewswire.com · Sep 2026Frequently asked questions
- What does Affera do?
- Affera develops a medical technology platform for treating cardiac arrhythmias, including atrial fibrillation, using innovative ablation solutions. The company serves cardiac electrophysiology specialists and healthcare systems treating arrhythmia patients.
- Who founded Affera?
- Affera was founded by Doron Harlev.
- Who are Affera's investors?
- Affera's investors include Bain Capital Life Sciences, Elysia Capital.
- Where is Affera headquartered?
- Affera is headquartered in Newton, US.